Capacités Biotherapeutics Solutions (CBS) is a business unit of CAPACITÉS LLC, the private subsidiary of Nantes Université, France, dedicated to the valorization of academic research and expertise. CBS provides the biopharmaceutical industry and research community with an easy access to complete range of services throughout all stages of gene-based drug development, such as:

  • Research-grade viral vector design and production
  • Development of GMP-compatible manufacturing processes for viral vectors, and related analytics
  • In vitro and in vivo preclinical proof-of-concept and dose finding studies, including in animal models of genetic diseases
  • Biodistribution, shedding and gene expression studies
  • Anatomopathological and histological analyses
  • Immune monitoring of preclinical and clinical studies
  • Integrated project management, including quality and regulatory supports
  • Scientific expertise and consulting for the translational development of gene therapy products

With more than 25 years of expertise in gene therapy, CBS collaborative and fee for services activities are closely related to high-level research teams of the TaRGeT laboratory (Translational Research in Gene Therapy, INSERM, Nantes Université), including the ViVeM, PAC and GTI platforms, the Boisbonne center (ONIRIS, Nantes veterinary school) and the APEX facility (INRAE, ONIRIS).
We dedicate our expertise to help you advance your gene therapy projects.


Get Involved with the Advanced Therapies Congress


To sponsor or exhibit

Ashlea Foster
+44 208 164 3032



To speak

Ila Dickinson
+44 207 092 1150